Thursday - April 18, 2024

Chronic Hepatitis B Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | Dicerna, GlaxoSmithKline, Ionis, Gilead, Roche, Janssen, Replicor, Arbutus Biopharma, Assembly Biosciences

Delveinsight Business Research LLP The Chronic Hepatitis B Market size in the 7MM was USD 1,500 million in 2022 and it is projected to increase during the forecast period (2023–2032). As per DelveInsight, the Chronic Hepatitis B Market is anticipated … Continue reading →

Inflammatory Bowel Disease (IBD) Market Anticipates Impressive Growth Trajectory Through 2032 – Asserts DelveInsight | Takeda, AstraZeneca, Janssen, Abbvie, Eli Lilly, Gilead, Galapagos

Delveinsight Business Research LLP As per DelveInsight, the Inflammatory Bowel Disease therapeutics market is anticipated to evolve immensely in the coming years owing to the expected launch of investigational drugs and the rise in the number of cases of Inflammatory … Continue reading →

Parkinson’s Disease Market Poised for Phenomenal Expansion During the Forecast Period (2023-32) – Estimates DelveInsight | AbbVie, Addex Pharma, Inhibikase, Amneal Pharma, Sunovion, Neuraly, NeuroDerm

Delveinsight Business Research LLP As per DelveInsight, the Parkinson’s Disease Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of Parkinson’s Disease and the launch of new therapies in the … Continue reading →

Myelofibrosis Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) – Estimates DelveInsight | AbbVie, Roche, Celgene, Cellenkos, Galecto, Geron, Incyte, Karyopharm

Delveinsight Business Research LLP The Myelofibrosis market size in the seven major markets is expected to increase during the study period (2019–2032) with a CAGR of 7.3%. As per DelveInsight, the Myelofibrosis Market is anticipated to evolve immensely in the … Continue reading →

Richter’s Syndrome Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Eli Lilly and Company, Merck Sharp & Dohme LLC, Vincerx

Delveinsight Business Research LLP As per DelveInsight, the Richter’s Syndrome Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of Richter’s Syndrome, improved understanding and rising awareness of this rare … Continue reading →

Peripheral Neuropathic Pain Market Poised for Extraordinary Growth During the Forecast Period (2023-32), Asserts DelveInsight | AlzeCure, Eli Lilly, Bayer, Eliem, SIMR Biotech, Aptinyx, Haisco Pharma

Delveinsight Business Research LLP As per DelveInsight, the Peripheral Neuropathic Pain Market is anticipated to evolve immensely in the coming years owing to the increasing incidence and prevalence of diabetes and cancer, which are leading cause of peripheral neuropathic pain … Continue reading →

DelveInsight’s Analysis: Spondylolisthesis Market 2032 Unveils Epidemiological Trends, Promising Pipeline Therapies, and Recent FDA, EMA, PDMA Approvals | Novadip Biosciences and Ankasa Regenerative

Spondylolisthesis Market (Albany, USA) DelveInsight’s “Spondylolisthesis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Spondylolisthesis, historical and forecasted epidemiology as well as the Spondylolisthesis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United … Continue reading →